Out-of-Pocket Charges for Rape Kits and Services for Sexual Assault Survivors March 18, 2022 Issue Brief Although federal legislation intends to provide no-cost rape kits to all survivors of sexual violence, some survivors still face out-of-pocket charges for minimum standard rape kit services as well as other medical care that takes place following a sexual assault. This brief examines the policies that impact coverage of health care services for survivors of sexual assault and identifies gaps in those programs and coverage for their care, particularly for women with private health insurance.
Medicare Part B Drugs: Cost Implications for Beneficiaries in Traditional Medicare and Medicare Advantage March 15, 2022 Issue Brief In the face of rising prescription drug costs, a large majority of the public supports federal efforts to lower drug spending. Policymakers are considering several proposals that would lower prescription drug costs. To better understand the potential out-of-pocket cost exposure that Medicare beneficiaries may face for Part B drugs, which are typically administered by physicians and other health care providers, we analyzed cost-sharing liability for these drugs in traditional Medicare and cost-sharing requirements in Medicare Advantage plans.
Vaccinating the World: How Does the U.S. Stack Up Against Other Donors? March 3, 2022 Issue Brief This analysis looks at the amount of funding for vaccines and the number of vaccine doses that have been donated to the global COVID-19 vaccine effort and standardizes these donations based on the size of donor economies.
Medicaid Coverage for Women February 17, 2022 Issue Brief This data note presents key data points describing the current state of the Medicaid program as it affects women.
Nov. 16 Web Briefing: Update on Women’s Health Policy November 16, 2021 Event The Supreme Court, Congress, and state policymakers are currently debating issues that are central to women’s health and well-being. Watch the KFF Women’s Health Policy team web briefing to learn more about the status and implications of these debates, from abortion to paid leave.
Efforts to Increase Marketplace Enrollment During Open Enrollment Could Boost Medicaid Coverage, Too November 4, 2021 Blog As the ninth open enrollment period for the Health Insurance Marketplaces begins, enhanced Marketplace premium help along with increased funding for outreach and enrollment assistance mean there are more affordable coverage options for the millions of people who remain uninsured and more help available to connect those individuals to coverage.
Rebuilding Title X: New Regulations for the Federal Family Planning Program November 3, 2021 Issue Brief This analysis highlights state-level data on the status of the Title X family planning program on the eve of the implementation of the new Biden Administration regulations for the program.
Rebuilding the Title X Family Planning Network Will Take Time, Despite Biden Administration Actions Issuing New Regulations and Additional Funding November 3, 2021 News Release A new KFF analysis highlights state-level data on the status of the Title X family planning program on the eve of the implementation of the new Biden Administration regulations for the program. To date, five states still have no Title X clinics, and seven states are still operating with less…
COVID-19 Deaths Among Older Adults During the Delta Surge Were Higher in States with Lower Vaccination Rates October 1, 2021 Blog This analysis looks at the relationship between vaccination rates and COVID-19 deaths for adults 65 and older since the Delta variant took hold, and finds that states with lower vaccination rates among adults ages 65 and older had higher death rates among older adults during this period.
Tracking Global COVID-19 Vaccine Equity: An Update September 22, 2021 Issue Brief This updated analysis looks at global COVID-19 vaccination efforts by income-level and region to assess the equity gap in both vaccination coverage and rates of administration. Overall, we find that low-income countries and countries in Africa are lagging behind, and based on current rates, are unlikely to meet global vaccination targets.